Short-term effects of transjugular intrahepatic portosystemic shunt (TIPS) on functional liver plasma flow in patients with advanced cirrhosis

Liver

Volumn 18, Issue 4, 1998, Pages 245-250

  Bar, Fabrizio ^a   Battista, Stefania ^a   Garello, Enrico ^a   Grosso, Maurizio ^b   Spalluto, Francesco ^b   Zanon, Eugenio ^b   Torchio, Mauro ^a   Molino, Gianpaolo ^a  

^a MOLINETTE HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

D sorbitol hepatic clearance; Functional liver plasma flow; Liver circulation; Portal hypertension; TIPS

Indexed keywords

SORBITOL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; ESOPHAGUS VARICES BLEEDING; FEMALE; HUMAN; LIVER BLOOD FLOW; LIVER CIRCULATION; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER VEIN; MALE; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PORTOSYSTEMIC ANASTOMOSIS; RECURRENT DISEASE;

EID: 0031756794     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0676.1998.tb00160.x     Document Type: Article

References (22)

1. RING E J, LAKE J R, ROBERTS J P, et al. Using transjugular intrahepatic portosystemic shunts to control variceal bleeding before liver transplantation. Ann Intern Med 1992; 116: 304-9.
2. KERLAN R K, LABERGE J M, GORDON R L, RING E J. Transjugular intrahepatic portosystemic shunts: current status. AJR Am J Roentgenol 1995; 164: 1059-66.
3. KAMATH P S, MCKUSICK M A. Transvenous intrahepatic portosystemic shunts. Gastroenterology 1996; 111: 1700-5.
4. QUIROGA J, SANGRO B, NÚÑEZ M, et al. Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral and hemodynamic parameters. Hepatology 1995; 21: 986-94.
5. OCHS A, RÖSSLE M, HAAG K, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995; 332: 1192-7.
6. SOMBERG K A, LAKE J R, TOMLANOVICH S J, LABERGE J M, FELDSTEIN V, BASS N M. Transjugular intrahepatic portosystemic shunts for refractory ascites: assessment of clinical and hormonal response and renal function. Hepatology 1995; 21: 709-16.
7. STANLEY A J, GILMOUR H M, GHOSH S, FERGUSON A, MCGILCHRIST A J. Transjugular intrahepatic portosystemic shunt as a treatment for protein-losing enteropathy caused by portal hypertension. Gastroenterology 1996; 111. 1679-82.
8. RODRÌGUEZ-LAIZ J M, BAÑARES, ECHENAGUSIA A, et al. Effects of transjugular intrahepatic portosystemic shunt (TIPS) on splanchnic and systemic hemodynamics, and hepatic function in patients with portal hypertension. Preliminary results. Dig Dis Sci 1995; 40: 2121-7.
9. RIGGIO O, MERLI M, PEDRETTI G, et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Incidence and risk factors. Dig Dis Sci 1996; 41: 578-84.
10. JALAN R, GOODAY R, O'CARROLL R E, REDHEAD D N, ELTON R A, HAYES P C. A prospective evaluation of changes in neuropsychological and liver function tests following transjugular intrahepatic portosystemic stent-shunt. J Hepatol 1995; 23: 697-705.
11. AZOULAY D, CASTAING D, DENNISON A, MARTINO W, EYRAUD D, BISMUTH H. Transjugular intrahepatic portosystemic shunt worsens the hyperdynamic circulatory state of the cirrhotic patient preliminary report of a prospective study. Hepatology 1994; 19: 129-32.
12. RÖSSLE M, SELLINGER M, OCHS A, HAAG K. Liver function and blood flow before and after TIPS. Hepatology 1993; 18: 285A.
13. SAHAGUN G, BENNER K G, BARTON R E, KELLER F S, ROSCH J. Encephalopathy, ascites, and hepatic synthetic function after TIPS for variceal hemorrhage. Hepatology 1992; 16: A80.
14. SANYAL A J, FREEDMAN A M, LUKETIC V A, et al. The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts. Gastroenterology 1997; 112: 889-98.
15. LOTTERER E, MOOSMÜLLER A, WENGERT A, HAHN E G, FLEIG W E. Effect of transjugular intrahepatic portal systemic shunt (TIPS) on liver function in patients with alcoholic cirrhosis. Hepatology 1993; 18: 283A.
16. LOTTERER E, MOOSMÜLLER A, WENGERT A, HAHN E G, FLEIG W E. Effects of transjugular intrahepatic portal systemic shunt (TIPS) on liver function in patients with alcoholic cirrhosis. Hepatology 1994; 20: 108A.
17. MOLINO G, CAVANNA A, AVAGNINA P, BALLARÉ M, TORCHIO M. Hepatic clearance of D-sorbitol. Noninvasive test for evaluating functional liver plasma flow. Dig Dis Sci 1987; 32: 753-8.
18. MOLINO G, AVAGNINA P, BALLARÉ M, et al. Combined evaluation of total and functional liver plasma flows and intrahepatic shunting. Dig Dis Sci 1991; 36: 1189-96.
19. GROSSO M, SPALLUTO F, ANSELMETTI G C, et al. Derivazione portosistemica intraepatica per via percutanea transgiugulare (TIPS). Esperienza preliminare e proposta di una nuova metodica. Radiol Med 1992; 84: 619-25.
20. PERARNAU J M, RAABE J J, SCHWING D, RUCIN B, ARBOGAST J, RÖSSLE M. Anastomose porto-cave transjugulaire. Expérience préliminaire. Ann Chir 1993; 47: 407-413.
21. HAAG K, OCHS A. Transjugular intrahepatic portosystemic stent-shunt in the treatment of portal hypertension. Curr Opin Gastroenterol 1993; 9: 435-40.
22. BERGMEYER H U, GRUBER W, GUTMANN I. D-Sorbitol. In: Bergmeyer H U ed. Methods of enzymatic analysis. Weinheim: Verlag Chemie, 1975: 1323-30.